Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Ascorbic acid encapsulated into negatively charged liposomes exhibits increased skin permeation, retention and enhances collagen synthesis by fibroblasts.

Maione-Silva L, de Castro EG, Nascimento TL, Cintra ER, Moreira LC, Cintra BAS, Valadares MC, Lima EM.

Sci Rep. 2019 Jan 24;9(1):522. doi: 10.1038/s41598-018-36682-9.


Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy.

Bohr A, Nascimento TL, Harmankaya N, Weisser JJ, Wang Y, Grohganz H, Rades T, Löbmann K.

Molecules. 2019 Jan 11;24(2). pii: E266. doi: 10.3390/molecules24020266.


Antiproliferative Activity and VEGF Expression Reduction in MCF7 and PC-3 Cancer Cells by Paclitaxel and Imatinib Co-encapsulation in Folate-Targeted Liposomes.

Peres-Filho MJ, Dos Santos AP, Nascimento TL, de Ávila RI, Ferreira FS, Valadares MC, Lima EM.

AAPS PharmSciTech. 2018 Jan;19(1):201-212. doi: 10.1208/s12249-017-0830-1. Epub 2017 Jul 5.


Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy.

Martens TF, Peynshaert K, Nascimento TL, Fattal E, Karlstetter M, Langmann T, Picaud S, Demeester J, De Smedt SC, Remaut K, Braeckmans K.

Eur J Pharm Sci. 2017 May 30;103:27-35. doi: 10.1016/j.ejps.2017.02.027. Epub 2017 Feb 20.


Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model.

Leite Nascimento T, Hillaireau H, Vergnaud J, Rivano M, Deloménie C, Courilleau D, Arpicco S, Suk JS, Hanes J, Fattal E.

Int J Pharm. 2016 Nov 30;514(1):103-111. doi: 10.1016/j.ijpharm.2016.06.125.


Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs.

Nascimento TL, Hillaireau H, Vergnaud J, Fattal E.

Nanomedicine (Lond). 2016 Jul;11(14):1865-87. doi: 10.2217/nnm-2016-5000. Epub 2016 Jul 7. Review.


Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor.

Dufaÿ Wojcicki A, Hillaireau H, Nascimento TL, Arpicco S, Taverna M, Ribes S, Bourge M, Nicolas V, Bochot A, Vauthier C, Tsapis N, Fattal E.

J Control Release. 2012 Sep 28;162(3):545-52. doi: 10.1016/j.jconrel.2012.07.015. Epub 2012 Jul 20.


Supplemental Content

Loading ...
Support Center